Green tea modulation of inducible nitric oxide synthase in hypoxic/reoxygenated cardiomyocytes

被引:18
|
作者
Agnetti, G
Bordoni, A
Angeloni, C
Leoncini, E
Guarnieri, C
Caldarera, CM
Biagi, PL
Hrelia, S
机构
[1] Univ Bologna, Dipartimento Biochim G Moruzzi, Ctr Studi & Rech Metab Cardiaco, I-4016 Bologna, Italy
[2] Univ Bologna, Dipartimento Biochim G Moruzzi, Ctr Ric Nutr, I-4016 Bologna, Italy
关键词
nitric oxide synthase; hypoxia/reoxygenation; green tea; catechins; cardiomyocytes;
D O I
10.1016/j.biochi.2005.01.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypoxia/reoxygenation (H/R) is one of the causes of the increased expression of inducible nitric oxide synthase (iNOS) in cardiomyocytes. Since an aberrant NOS induction has detrimental consequences, we evaluated the effect of a green tea extract (GTE) on the NOS induction and activity in HIR-cardiomyocytes to define a nutritional strategy. Cultured rat cardiomyocytes were exposed to H/R in the presence of two concentrations of a green tea extract (GTE), which is reported to inhibit NOS expression and activity in different cells. In cultured cardiomyocytes two NOS isoforms were constitutively expressed, but only iNOS was induced by H/R. GTE supplementation at the lowest concentration, comparable to that in human plasma after dietary consumption, was ineffective, while the highest, comparable to that achievable by dietary supplements, counteracted the effect of H/R on iNOS induction and activity. It is necessary to verify in humans the relationship between the modulation of NO production and green tea dietary consumption. (c) 2005 Elsevier SAS. All rights reserved.
引用
收藏
页码:457 / 460
页数:4
相关论文
共 50 条
  • [41] Inducible Nitric Oxide Synthase and Inflammatory Diseases
    Ruben Zamora
    Yoram Vodovotz
    Timothy R. Billiar
    Molecular Medicine, 2000, 6 : 347 - 373
  • [42] Redox couples of inducible nitric oxide synthase
    1600, American Chemical Society, Columbus, United States (127):
  • [43] Antifibrotic role of inducible nitric oxide synthase
    Ferrini, MG
    Vernet, D
    Magee, TR
    Shahed, A
    Qian, A
    Rajfer, J
    Gonzalez-Cadavid, NF
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2002, 6 (03): : 283 - 294
  • [44] Regulation of the expression of inducible nitric oxide synthase
    Kleinert, H
    Pautz, A
    Linker, K
    Schwarz, PM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 500 (1-3) : 255 - 266
  • [45] Inducible nitric oxide synthase and blood pressure
    Mattson, DL
    Maeda, CY
    Bachman, TD
    Cowley, AW
    HYPERTENSION, 1998, 31 (01) : 15 - 20
  • [46] Inducible nitric oxide synthase and blood pressure
    Mattson, DL
    Maeda, CY
    Cowley, AW
    HYPERTENSION, 1996, 28 (03) : P174 - P174
  • [47] Inducible nitric oxide synthase: Good or bad?
    Lind, Maggie
    Hayes, Alan
    Caprnda, Martin
    Petrovic, Daniel
    Rodrigo, Luis
    Kruzliak, Peter
    Zulli, Anthony
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 93 : 370 - 375
  • [48] Inducible nitric oxide synthase and inflammatory diseases
    Zamora, R
    Vodovotz, Y
    Billiar, TR
    MOLECULAR MEDICINE, 2000, 6 (05) : 347 - 373
  • [49] The regulation of inducible nitric oxide synthase by noradrenaline
    Feinstein, DL
    Gavrilyuk, V
    Dello Russo, C
    Galea, E
    GLIA, 2003, : 2 - 2
  • [50] Regulation of the expression of inducible nitric oxide synthase
    Pautz, Andrea
    Art, Julia
    Hahn, Susanne
    Nowag, Sebastian
    Voss, Cornelia
    Kleinert, Hartmut
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2010, 23 (02): : 75 - 93